Long-term Consistent Use of a Vaginal Microbicide Gel among HIV-1 Sero-discordant Couples in a Phase III Clinical Trial (MDP 301) in Rural South-west Uganda

This article, published in the 1 February 2013 issue of the online journal Trials, reports on an assessment of the factors associated with consistent gel use in the MDP 301 clinical trial to assess the microbicide candidate PRO 2000 among HIV-negative women in serodiscordant couples in southwestern Uganda. The study found that women 25 years or older and those living in a household with three or more rooms for sleeping compared with one room were more likely to report consistent use of the gel.

9 pages
MRC/UVRI Uganda Research Unit on AIDS, MRC Clinical Trials Unit, Wits Reproductive Health and HIV Institute. London School of Hygiene and Tropical Medicine
Abaasa A, Crook A, Gafos M, Anywaine Z, Levin J, Wandiembe S, Nanoo A, S, Hayes R, Kamali A